Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: USANA Health Sciences’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:35 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000896264-26-000034
| Line item | Three months ended / April 4,2026 | Three months ended / March 29,2025 |
|---|---|---|
| Cash flows from investing activities | ||
| Payments for net investment hedge | — | (1,072) |
| Proceeds from sale of property and equipment | 48 | — |
| Purchases of property and equipment | (2,645) | (2,803) |
| Net cash provided by (used in) investing activities | (2,597) | (3,875) |
| Cash flows from financing activities | ||
| Repurchase of common stock | — | (12,300) |
| Borrowings on line of credit | 4,000 | — |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is USANA Health Sciences's capex?
- USANA Health Sciences (USNA) reported capex of $2.65M in Q1 2026.
- How has USANA Health Sciences's capex changed year-over-year?
- USANA Health Sciences's capex decreased by 5.6% year-over-year, from $2.8M to $2.65M.
- What is the long-term trend for USANA Health Sciences's capex?
- Over 4 years (2021 to 2025), USANA Health Sciences's capex has grown at a 2.0% compound annual growth rate (CAGR), from $12.76M to $13.82M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about USANA Health Sciences's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude